Avricore Health Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 0.629241 million compared to CAD 0.042736 million a year ago. Net loss was CAD 0.191512 million compared to CAD 0.185678 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 CAD | -3.12% | 0.00% | -8.82% |
Apr. 30 | Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 04 | Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations | MT |
1st Jan change | Capi. | |
---|---|---|
-8.82% | 11.37M | |
+38.01% | 705B | |
+32.33% | 583B | |
-3.46% | 364B | |
+20.27% | 332B | |
+5.12% | 291B | |
+16.94% | 238B | |
-3.48% | 210B | |
+10.47% | 209B | |
+8.73% | 169B |
- Stock Market
- Equities
- AVCR Stock
- News Avricore Health Inc.
- Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023